Clinical Trial Update: Extended Safety Study of Tenofovir Disoproxil Fumarate (TDF) Among HIV-1 Negative Men [Phase 2]

View source ↗

Summary

Phase 2 extended safety study of tenofovir disoproxil fumarate (Viread) in HIV-1 negative men, reporting safety and tolerability results for HIV pre-exposure co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Viread (tenofovir disoproxil fumarate)

Snippet

Sponsor: Centers for Disease Control and Prevention | Conditions: HIV Infection | Phase 2 | Status: COMPLETED | Results posted: 2014-03-10